
SPARK-TECH, founded in 2015 and based in Krakow, Poland, is a pioneer in revolutionizing medical and biological research. The company develops innovative, autonomous, user-friendly, and affordable laboratory equipment powered by artificial intelligence, robotics, and information engineering. Their key products include the Spark-Tech Biobanking System (STBS) and the Spark-Tech Isolation and Biobanking System (STIBS), which offer automated solutions for blood separation, cell cryopreservation, and biobanking. SPARK-TECH also provides microbiome sequencing services for humans and agriculture, aiming to reduce antibiotic use. The company has secured significant funding from European Union and national programs for its R&D projects, including a €2.6 million grant for STBS. SPARK-TECH's business model likely involves selling its specialized laboratory equipment and offering related services like sequencing.

SPARK-TECH, founded in 2015 and based in Krakow, Poland, is a pioneer in revolutionizing medical and biological research. The company develops innovative, autonomous, user-friendly, and affordable laboratory equipment powered by artificial intelligence, robotics, and information engineering. Their key products include the Spark-Tech Biobanking System (STBS) and the Spark-Tech Isolation and Biobanking System (STIBS), which offer automated solutions for blood separation, cell cryopreservation, and biobanking. SPARK-TECH also provides microbiome sequencing services for humans and agriculture, aiming to reduce antibiotic use. The company has secured significant funding from European Union and national programs for its R&D projects, including a €2.6 million grant for STBS. SPARK-TECH's business model likely involves selling its specialized laboratory equipment and offering related services like sequencing.